Skills Alliance Revenue and Competitors

London, UK

Location

N/A

Total Funding

Recruiting

Industry

Estimated Revenue & Valuation

  • Skills Alliance's estimated annual revenue is currently $20.9M per year.(i)
  • Skills Alliance's estimated revenue per employee is $132,000

Employee Data

  • Skills Alliance has 158 Employees.(i)
  • Skills Alliance grew their employee count by 48% last year.

Skills Alliance's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP - East Coast | Pre-Clinical I Scientific | Executive SearchReveal Email/Phone
3
Managing Director, Skills Alliance ConsultingReveal Email/Phone
4
Program ManagerReveal Email/Phone
5
Compliance ManagerReveal Email/Phone
6
Team Manager - Global Clinical DivisionReveal Email/Phone
7
RecruiterReveal Email/Phone
8
Senior QA Consultant, Medical Devices ContractReveal Email/Phone
9
Principal ConsultantReveal Email/Phone
10
Principal Consultant, Medical Communications - New YorkReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M140%N/AN/A
#2
$3.9M4128%N/AN/A
#3
$4.8M50-12%N/AN/A
#4
$1.7M200%N/AN/A
#5
$0.9M120%N/AN/A
#6
$4.4M46-40%N/AN/A
#7
$4.1M4339%N/AN/A
#8
$12.8M1078%N/AN/A
#9
$1.7M2011%N/AN/A
#10
$7M6512%N/AN/A
Add Company

What Is Skills Alliance?

Established in 2005, Skills Alliance was conceived to take advantage of a surge in demand for talented pharmaceutical industry professionals, to drive the development and bringing to market of new pharmaceutical compounds. From the outset we have fostered a culture of delivering excellence in service, using the latest recruitment methodologies available, whilst maintaining transparency and accountability every step of the way. Our internal structure is set up to mirror the full drug development life-cycle, with specialist teams responsible for each vertical area, from the pre-clinical discovery phase through to the commercialisation of the drug. To date we count many of the leading pharmaceutical, biotechnology, biopharma and CROs as our partners, and we are proud to be contributing to the discovery, development and distribution of safe and effective therapeutics across the globe. A specialist area of focus for the team at Skills Alliance is Business Transformation and EMEA / Global launch projects. We offer a bespoke solution designed to assist fast growing Biotechnology & Pharmaceutical companies in securing the best possible executive staff for their business. This ranges from new project launch teams for impending drug approvals through to full global or EMEA management build out projects. Specialist Disciplines Include: Drug Discovery and R&D Clinical Research Pharmaceutical Quality Assurance Clinical Data Management Biostatistics Drug Safety and Pharmacovigilance Regulatory Affairs Medical Information Medical Affairs Pharmaceutical Manufacturing Health Economics and Outcomes Research Government Affairs & Policy Medical Devices and Technology Regional Locations: London New York Seattle California Zurich For more information, please contact one of the leadership team members - call +44 207 220 6200 / +1 646-492-5300 or email info@skillsalliance.com

keywords:N/A

N/A

Total Funding

158

Number of Employees

$20.9M

Revenue (est)

48%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Skills Alliance News

2022-04-19 - Alliance YMCA staff details campaign, community efforts

Acuff, executive director of Alliance Family YMCA and ... as to help students to develop problem-solving skills and empower their lives.

2022-04-19 - Connecticut Braver Angels to Host Skills for Bridging the ...

The Braver Angels Connecticut Alliance encourages residents to attend national Braver Angels events—workshops, book and film clubs, national...

2022-04-17 - Alliance High students score well at jobs program event

Students showcase their skills in twelve events centered on “soft skills” required to get and keep a quality job.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.8M1587%N/A
#2
$25.2M1583%N/A
#3
$56.1M15820%N/A
#4
$46.9M1585%N/A
#5
$46.9M1587%N/A